NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1689038671 MD
Verify on CMS → Michael Bautista, MD
Ophthalmology Physician in Westport, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,090 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
587
Medicare Part D claims · 205 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.8/100
▲ 6 pts above national avg 83.1 · Above neutral
Industry payments
$450.41
12 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Michael Bautista, MD reported a CMS MIPS final score of 88.8/100 - above the 83.1 national average - and filed 587 Medicare Part D claims in 2023.
- 88.8/100
- MIPS score · +6 vs avg
- 587
- Part D claims, 2023
- 64%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Bautista, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
89 Top 44% higher than 56% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Bautista, MD sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Bautista, MD writes more Part D claims than 29% of them and scores higher on MIPS quality than 53% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Michael Bautista, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Bautista, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Bautista, MD?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
587 59% vs specialty avg
MIPS final score
88.8/100 5.7 pts vs avg
Specialty distribution in Connecticut
How Ophthalmology Physician compares to other specialties among Connecticut providers
Medicare quality performance, MIPS
Michael Bautista, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 88.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 88.8/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Bautista, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 129 KINGS HWY N, Westport, CT, 06880, with a listed phone of (203) 227-4113. NPI 1689038671 was issued on 04/06/2016.
Medicare Part D records for calendar year 2023 show 587 prescription claims written by this provider, covering 205 Medicare beneficiaries and totaling roughly $85K in drug spend, split 36% brand-name and 64% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.8/100 for the 2023 performance year (Quality 100, Cost 62.6), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1689038671 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/06/2016 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
88.789
Final Score
Avg: 83.1
100
Quality
62.63
Cost
Reporting: Group practice
Hospital and facility affiliations
Facilities where Michael Bautista, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Richard A Fichman MD PC
Westport, CT
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Bautista, MD. Source: openpaymentsdata.cms.gov.
Total received
$450
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Michael Bautista, MD - brand share 36.0%
Ophthalmology Physician average
36% brand-name claims vs 64% generic, on 587 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
587
Total Claims
$85K
Total Drug Cost
205
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 827
- Total Day Supply
- 21,209
- Brand vs Generic
- 36% brand / 64% generic
- Brand Drug Cost
- $74K
- Generic Drug Cost
- $11K
- Antibiotic Claims
- 35
Patient Demographics
- Average Patient Age
- 76.0 years
- Avg HCC Risk Score
- 1.10
- Gender Split
- 64% female / 36% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Bautista, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
95 claims
- Timolol Maleate
Timolol Maleate
78 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
69 claims
- Erythromycin 37
Erythromycin
37 claims
- Restasis 34
Restasis
34 claims
- Dorzolamide-Timolol 30
Dorzolamide-Timolol
30 claims
- Prednisolone Acetate 29
Prednisolone Acetate
29 claims
- Doxycycline Hyclate 28
Doxycycline Hyclate
28 claims
| Drug | Claims |
|---|---|
| Latanoprost | 95 |
| Timolol Maleate | 78 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 69 |
| Erythromycin Erythromycin Base | 37 |
| Restasis Cyclosporine | 34 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 30 |
| Prednisolone Acetate | 29 |
| Doxycycline Hyclate | 28 |
| Valacyclovir Valacyclovir Hcl | 26 |
| Alphagan P Brimonidine Tartrate | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Michael Bautista, MD fits within the Ophthalmology Physician landscape nationally.
22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Michael Bautista, MD's 587 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Bautista.
Dr. Michael Abrams
M.D.
Danbury, CT
Dr. Marcio Abreu
M.D.
Bridgeport, CT
Dr. Bruce Altman
M.D.
Danbury, CT
Dr. Laura Andrews
MD
Waterbury, CT
Shimy Apoorva
Waterbury, CT
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Connecticut
Frequently Asked Questions
What is Michael Bautista, MD's specialty? ▼
Michael Bautista, MD specializes in Ophthalmology Physician and practices in Westport, Connecticut. Credentials: MD.
How much does Michael Bautista, MD prescribe under Medicare Part D? ▼
In 2023, Michael Bautista, MD wrote 587 Medicare Part D claims totaling $85K in drug costs for 205 beneficiaries.
What is Michael Bautista, MD's Medicare quality score? ▼
Michael Bautista, MD has a CMS MIPS Final Score of 88.8/100 (Quality: 100, Cost: 62.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Bautista, MD located? ▼
Michael Bautista, MD is located at 129 KINGS HWY N, Westport, CT, 06880. Phone: (203) 227-4113.
What is Michael Bautista, MD's NPI number? ▼
Michael Bautista, MD's National Provider Identifier (NPI) is 1689038671, issued on 04/06/2016.
Does Michael Bautista, MD prescribe more brand-name or generic drugs? ▼
Michael Bautista, MD's prescribing is 36% brand-name and 64% generic drugs by claim count, with $74K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Michael Bautista, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Bautista, MD's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Bautista, MD accept Medicare? ▼
Michael Bautista, MD appears in CMS Medicare data with 587 Part D claims and 205 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Bautista, MD's credentials? ▼
Michael Bautista, MD's NPI is 1689038671 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.